Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin...

12/09/22

Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy The Business Journals

[more]

Feeds Categories:
- 363 Sales,
- News,
- 363Sales